Edition:
India

Evotec AG (EVTG.DE)

EVTG.DE on Xetra

14.43EUR
20 Apr 2018
Change (% chg)

€-0.50 (-3.35%)
Prev Close
€14.93
Open
€14.85
Day's High
€14.85
Day's Low
€14.39
Volume
520,146
Avg. Vol
1,467,049
52-wk High
€22.50
52-wk Low
€10.35

Select another date:

Wed, Apr 18 2018

BRIEF-Evotec Says Endometriosis Programme With Bayer Moves To Phase I Development

* DGAP-NEWS: EVOTEC AND BAYER ADVANCE THIRD ENDOMETRIOSIS PROGRAMME INTO PHASE I CLINICAL DEVELOPMENT Source text for Eikon: Further company coverage:

BRIEF-Evotec AG Says ‍Plans Conversion Into European Company​

* SAYS ‍PLANS CONVERSION INTO EUROPEAN COMPANY​ Source text for Eikon: Further company coverage: (Reporting by Frankfurt Newsroom)

Sanofi, Evotec team up for research on infectious diseases treatment

PARIS Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.

BRIEF-Evotec, Apeiron Biologics receive milestone payment from Sanofi

* SAYS ‍EVOTEC AND APEIRON ACHIEVE FIRST MILESTONE IN IMMUNO-ONCOLOGY ALLIANCE WITH SANOFI​

BRIEF-Evotec receives milestone payment from Boehringer Ingelheim​

* SAYS ‍EVOTEC RECEIVES CLINICAL MILESTONE AS PART OF ITS DISCOVERY ALLIANCE WITH BOEHRINGER INGELHEIM

BRIEF-Evotec affirms guidance after 9-month core profit jump

* ‍9M adjusted group EBITDA up 28% to eur 39.3 m (9m 2016: eur 30.6 m)​

BRIEF-Evotec, Tesaro enter partnership on novel immuno-oncology agents

* dgap-news: evotec and tesaro enter strategic partnership to discover novel immuno-oncology agents

Select another date: